Protective effect of vitamin D on high glucose-induced podocyte insulin resistance
ZOU Minshu1, YU Jian1, NIE Guoming1, LUO Liman1, XU Hongtao1, YIN Xiaoling2, ZHOU Jianhua2
(1. Department of pediatrics, Wuhan General Hospital of Guangzhou Command of PLA, Wuhan 430070，China; 2. Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China)
ZOU Minshu,YU Jian,NIE Guoming,LUO Liman,XU Hongtao,YIN Xiaoling,ZHOU Jianhua. Protective effect of vitamin D on high glucose-induced podocyte insulin resistance [J]., 2014, 32(5): 471-475.
[1] Welsh GI，Hale LJ，Eremina V，et al. Insulin signaling to the glomerular podocyte is critical for normal kidney function[J]. Cell Metab，2010，12(4)：329-340. [2] de Zeeuw D，Agarwal R，Amdahl M，et al. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study)：a randomised controlled trial [J]. Lancet，2010，376(9752)：1543-1551. [3] 邹敏书，余健，聂国明，等. 帕立骨化醇对糖尿病大鼠肾脏保护作用的机制探讨[J].解放军药学学报，2011，27(6)：476-479. [4] Ma J，Zhang B，Liu S，et al. 1，25-Dihydroxyvitamin D(3) inhibits podocyte uPAR expression and reduces proteinuria[J]. PLoS One，2013，8(5)：e64912. [5] Coward RJ，Saleem MA. Podocytes as a target of insulin[J]. Curr Diabetes Rev，2011，7(1)：22-27. [6] Copps KD，White MF. Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2[J]. Diabetologia，2012，55(10)：2565-2582. [7] Fornoni A. Proteinuria，the podocyte，and insulin resistance[J]. N Engl J Med，2010，363(21)：2068-2069. [8] Yu Q，Gao F，Ma XL. Insulin says NO to cardiovascular disease[J]. Cardiovasc Res，2011，89(3)：516-524. [9] Tang YC，Liu CW，Chang HH，et al. Endothelin-1 stimulates resistin gene expression[J]. Endocrinology，2014 ，155（3）：854-864. [10] Liu HY，Collins QF，Xiong Y，et al. Prolonged treatment of primary hepatocytes with oleate induces insulin resistance through p38 mitogen-activated protein kinase[J]. J Biol Chem，2007，282(19)：14205-14212. [11] Du P，Fan B，Han H，et al. NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy[J]. Kidney Int，2013，84(2)：265-276. [12] De Cosmo S，Menzaghi C，Prudente S，et al. Role of insulin resistance in kidney dysfunction： insights into the mechanism and epidemiological evidence[J]. Nephrol Dial Transplant，2013，28(1)：29-36. [13] 李海园，刘志伟. 维生素D的免疫调节作用与儿童疾病[J].临床儿科杂志，2012，30（8）：792-794. [14] Karnchanasorn R，Ou HY，Chiu KC. Plasma 25-hydroxyvitamin D levels are favorably associated with β-cell function[J]. Pancreas，2012，41(6)：863-868. [15] von Hurst PR，Stonehouse W，Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient-a randomised，placebo-controlled trial[J]. Br J Nutr，2010，103(4)：549-555. [16] Al-Daghri NM，Al-Attas OS，Alokail MS，et al. Hypovitaminosis D associations with adverse metabolic parameters are accentuated in patients with Type 2 diabetes mellitus： a body mass index-independent role of adiponectin? [J].J Endocrinol Invest，2013，36(1)：1-6. [17] Marcotorchino J，Gouranton E，Romier B，et al. Vitamin D reduces the inflammatory response and restores glucose uptake in adipocytes[J]. Mol Nutr Food Res，2012，56(12)：1771-1782. [18] Wang Y，Deb DK，Zhang Z，et al. Vitamin D receptor signaling in podocytes protects against diabetic nephropathy[J]. J Am Soc Nephrol，2012，23(12)：1977-1986. [19] 邹敏书，余健，周建华，等. 活性维生素D及其类似物对足细胞的保护作用[J].临床儿科杂志，2012，30（1）：93-96. [20] 许桂平，于明香.维生素D与糖尿病[J].复旦学报(医学版).2011，38(1)：80-83.
